Opthea Successfully Completes Institutional Offer and Increases Capital Raising to A$90.0m (US$57.6 million¹)
Retrieved on:
Monday, August 28, 2023
New Options Initiative (For Youth), OPT, ASIC, Date, Placement, AMD, Model Business Corporation Act, S&P/ASX 200, ASX, Corporations Act 2001, Entitlement, Prospectus, Corporation, US, Shore, CTH, Institution, Option, Patient, COAST, Cryptocurrency, Rare-earth element, Security (finance), Pharmaceutical industry
The non-underwritten institutional placement (Placement) and the institutional component (Institutional Entitlement Offer) of the fully underwritten 1 for 3.07 pro-rata accelerated non-renounceable entitlement offer (Entitlement Offer) together raised approximately A$73.7m.
Key Points:
- The non-underwritten institutional placement (Placement) and the institutional component (Institutional Entitlement Offer) of the fully underwritten 1 for 3.07 pro-rata accelerated non-renounceable entitlement offer (Entitlement Offer) together raised approximately A$73.7m.
- Approximately 160.2m shares will be issued under the Placement and the Institutional Entitlement Offer (New Shares) at an offer price of A$0.46 per New Share.
- Eligible institutional shareholders took up approximately 47.0% of their entitlements with the shortfall placed to both new and existing institutional shareholders.
- Trading Halt and announcement of the Equity Raising, lodgement of Offer Documents, including Prospectus with ASIC
Announcement of completion of the Institutional Entitlement offer, trading halt lifted, existing securities recommence trading